Rikoon Group LLC held its stake in Colgate-Palmolive (NYSE:CL) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,448 shares of the company’s stock at the end of the second quarter. Rikoon Group LLC’s holdings in Colgate-Palmolive were worth $552,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. American Beacon Advisors Inc. purchased a new position in Colgate-Palmolive in the 1st quarter valued at $102,000. Proficio Capital Partners LLC lifted its holdings in Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after purchasing an additional 207 shares in the last quarter. OLD Second National Bank of Aurora purchased a new position in Colgate-Palmolive in the 2nd quarter valued at $109,000. Krilogy Financial LLC lifted its holdings in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after purchasing an additional 289 shares in the last quarter. Finally, Harbour Capital Advisors LLC purchased a new position in Colgate-Palmolive in the 1st quarter valued at $121,000. Hedge funds and other institutional investors own 72.96% of the company’s stock.

Shares of Colgate-Palmolive (NYSE:CL) opened at $73.32 on Monday. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. The stock has a market capitalization of $64,382.68, a PE ratio of 25.55, a P/E/G ratio of 3.36 and a beta of 0.81. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period last year, the company earned $0.73 EPS. The company’s quarterly revenue was up 2.8% on a year-over-year basis. analysts predict that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.

A number of brokerages have issued reports on CL. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research note on Thursday, August 24th. Macquarie began coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price for the company. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, September 20th. Morgan Stanley raised Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $75.00 to $84.00 in a research note on Monday, September 25th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Two analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $76.04.

In related news, insider Victoria L. Dolan sold 9,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the transaction, the director now owns 36,268 shares of the company’s stock, valued at $2,557,619.36. The disclosure for this sale can be found here. Insiders have sold a total of 173,673 shares of company stock valued at $12,629,293 over the last 90 days. 1.02% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/12/11/rikoon-group-llc-continues-to-hold-position-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.